Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Aug;108(Suppl 4):697–704. doi: 10.1289/ehp.00108s4697

Occupational asthma: a review.

L J Lombardo 1, J R Balmes 1
PMCID: PMC1637677  PMID: 10931788

Abstract

Occupational asthma is the most common form of occupational lung disease in the developed world at the present time. In this review, the epidemiology, pathogenesis/mechanisms, clinical presentations, management, and prevention of occupational asthma are discussed. The population attributable risk of asthma due to occupational exposures is considerable. Current understanding of the mechanisms by which many agents cause occupational asthma is limited, especially for low-molecular-weight sensitizers and irritants. The diagnosis of occupational asthma is generally established on the basis of a suggestive history of a temporal association between exposure and the onset of symptoms and objective evidence that these symptoms are related to airflow limitation. Early diagnosis, elimination of exposure to the responsible agent, and early use of inhaled steroids may play important roles in the prevention of long-term persistence of asthma. Persistent occupational asthma is often associated with substantial disability and consequent impacts on income and quality of life. Prevention of new cases is the best approach to reducing the burden of asthma attributable to occupational exposures. Future research needs are identified.

Full text

PDF
697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts W. M., do Pico G. A. Reactive airways dysfunction syndrome. Chest. 1996 Jun;109(6):1618–1626. doi: 10.1378/chest.109.6.1618. [DOI] [PubMed] [Google Scholar]
  2. Ameille J., Pairon J. C., Bayeux M. C., Brochard P., Choudat D., Conso F., Devienne A., Garnier R., Iwatsubo Y. Consequences of occupational asthma on employment and financial status: a follow-up study. Eur Respir J. 1997 Jan;10(1):55–58. doi: 10.1183/09031936.97.10010055. [DOI] [PubMed] [Google Scholar]
  3. Axon E. J., Beach J. R., Burge P. S. A comparison of some of the characteristics of patients with occupational and non-occupational asthma. Occup Med (Lond) 1995 Apr;45(2):109–111. doi: 10.1093/occmed/45.2.109. [DOI] [PubMed] [Google Scholar]
  4. Balboni A., Baricordi O. R., Fabbri L. M., Gandini E., Ciaccia A., Mapp C. E. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J. 1996 Feb;9(2):207–210. doi: 10.1183/09031936.96.09020207. [DOI] [PubMed] [Google Scholar]
  5. Balmes J. R. Surveillance for occupational asthma. Occup Med. 1991 Jan-Mar;6(1):101–110. [PubMed] [Google Scholar]
  6. Bhérer L., Cushman R., Courteau J. P., Quévillon M., Côté G., Bourbeau J., L'Archevêque J., Cartier A., Malo J. L. Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended. Occup Environ Med. 1994 Apr;51(4):225–228. doi: 10.1136/oem.51.4.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bignon J. S., Aron Y., Ju L. Y., Kopferschmitt M. C., Garnier R., Mapp C., Fabbri L. M., Pauli G., Lockhart A., Charron D. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med. 1994 Jan;149(1):71–75. doi: 10.1164/ajrccm.149.1.8111601. [DOI] [PubMed] [Google Scholar]
  8. Blanc P. D., Cisternas M., Smith S., Yelin E. H. Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest. 1996 Mar;109(3):688–696. doi: 10.1378/chest.109.3.688. [DOI] [PubMed] [Google Scholar]
  9. Blanc P. D., Galbo M., Hiatt P., Olson K. R. Morbidity following acute irritant inhalation in a population-based study. JAMA. 1991 Aug 7;266(5):664–669. [PubMed] [Google Scholar]
  10. Blanc P. D., Jones M., Besson C., Katz P., Yelin E. Work disability among adults with asthma. Chest. 1993 Nov;104(5):1371–1377. doi: 10.1378/chest.104.5.1371. [DOI] [PubMed] [Google Scholar]
  11. Blanc P. Occupational asthma in a national disability survey. Chest. 1987 Oct;92(4):613–617. doi: 10.1378/chest.92.4.613. [DOI] [PubMed] [Google Scholar]
  12. Bright P., Burge P. S. Occupational lung disease. 8. The diagnosis of occupational asthma from serial measurements of lung function at and away from work. Thorax. 1996 Aug;51(8):857–863. doi: 10.1136/thx.51.8.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brooks S. M., Hammad Y., Richards I., Giovinco-Barbas J., Jenkins K. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest. 1998 Jan;113(1):42–49. doi: 10.1378/chest.113.1.42. [DOI] [PubMed] [Google Scholar]
  14. Brooks S. M., Weiss M. A., Bernstein I. L. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985 Sep;88(3):376–384. doi: 10.1378/chest.88.3.376. [DOI] [PubMed] [Google Scholar]
  15. Cannon J., Cullinan P., Newman Taylor A. Consequences of occupational asthma. BMJ. 1995 Sep 2;311(7005):602–603. doi: 10.1136/bmj.311.7005.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chan-Yeung M. Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest. 1995 Oct;108(4):1084–1117. doi: 10.1378/chest.108.4.1084. [DOI] [PubMed] [Google Scholar]
  17. Chan-Yeung M., Lam S., Koener S. Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata). Am J Med. 1982 Mar;72(3):411–415. doi: 10.1016/0002-9343(82)90497-1. [DOI] [PubMed] [Google Scholar]
  18. Chan-Yeung M., Malo J. L. Aetiological agents in occupational asthma. Eur Respir J. 1994 Feb;7(2):346–371. doi: 10.1183/09031936.94.07020346. [DOI] [PubMed] [Google Scholar]
  19. Chan-Yeung M., Malo J. L. Occupational asthma. N Engl J Med. 1995 Jul 13;333(2):107–112. doi: 10.1056/NEJM199507133330207. [DOI] [PubMed] [Google Scholar]
  20. Chang-Yeung M., Lam S., Kennedy S. M., Frew A. J. Persistent asthma after repeated exposure to high concentrations of gases in pulpmills. Am J Respir Crit Care Med. 1994 Jun;149(6):1676–1680. doi: 10.1164/ajrccm.149.6.8004329. [DOI] [PubMed] [Google Scholar]
  21. Contreras G. R., Rousseau R., Chan-Yeung M. Occupational respiratory diseases in British Columbia, Canada in 1991. Occup Environ Med. 1994 Oct;51(10):710–712. doi: 10.1136/oem.51.10.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Cote J., Kennedy S., Chan-Yeung M. Outcome of patients with cedar asthma with continuous exposure. Am Rev Respir Dis. 1990 Feb;141(2):373–376. doi: 10.1164/ajrccm/141.2.373. [DOI] [PubMed] [Google Scholar]
  23. Cullinan P., Lowson D., Nieuwenhuijsen M. J., Gordon S., Tee R. D., Venables K. M., McDonald J. C., Newman Taylor A. J. Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to laboratory rats. Occup Environ Med. 1994 Sep;51(9):589–592. doi: 10.1136/oem.51.9.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Demnati R., Fraser R., Ghezzo H., Martin J. G., Plaa G., Malo J. L. Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats. Eur Respir J. 1998 Apr;11(4):922–928. doi: 10.1183/09031936.98.11040922. [DOI] [PubMed] [Google Scholar]
  25. Frew A., Chan H., Salari H., Chan-Yeung M. Is tyrosine kinase activation involved in basophil histamine release in asthma due to western red cedar? Allergy. 1998 Feb;53(2):139–143. doi: 10.1111/j.1398-9995.1998.tb03861.x. [DOI] [PubMed] [Google Scholar]
  26. Frew A., Chang J. H., Chan H., Quirce S., Noertjojo K., Keown P., Chan-Yeung M. T-lymphocyte responses to plicatic acid-human serum albumin conjugate in occupational asthma caused by western red cedar. J Allergy Clin Immunol. 1998 Jun;101(6 Pt 1):841–847. doi: 10.1016/S0091-6749(98)70313-6. [DOI] [PubMed] [Google Scholar]
  27. Gallagher J. S., Tse C. S., Brooks S. M., Bernstein I. L. Diverse profiles of immunoreactivity in toluene diisocyanate (TDI) asthma. J Occup Med. 1981 Sep;23(9):610–616. doi: 10.1097/00043764-198109000-00009. [DOI] [PubMed] [Google Scholar]
  28. Gannon P. F., Belcher J., Pantin C. F., Burge P. S. The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow. Eur Respir J. 1999 Jul;14(1):28–31. doi: 10.1034/j.1399-3003.1999.14a07.x. [DOI] [PubMed] [Google Scholar]
  29. Gannon P. F., Weir D. C., Robertson A. S., Burge P. S. Health, employment, and financial outcomes in workers with occupational asthma. Br J Ind Med. 1993 Jun;50(6):491–496. doi: 10.1136/oem.50.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gassert T. H., Hu H., Kelsey K. T., Christiani D. C. Long-term health and employment outcomes of occupational asthma and their determinants. J Occup Environ Med. 1998 May;40(5):481–491. doi: 10.1097/00043764-199805000-00011. [DOI] [PubMed] [Google Scholar]
  31. Gautrin D., Boulet L. P., Boutet M., Dugas M., Bhérer L., L'Archevêque J., Laviolette M., Côté J., Malo J. L. Is reactive airways dysfunction syndrome a variant of occupational asthma? J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):12–22. doi: 10.1016/0091-6749(94)90228-3. [DOI] [PubMed] [Google Scholar]
  32. Jajosky R. A., Harrison R., Reinisch F., Flattery J., Chan J., Tumpowsky C., Davis L., Reilly M. J., Rosenman K. D., Kalinowski D. Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments--California, Massachusetts, Michigan, and New Jersey, 1993-1995. MMWR CDC Surveill Summ. 1999 Jun 25;48(3):1–20. [PubMed] [Google Scholar]
  33. Kern D. G. Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acid. Am Rev Respir Dis. 1991 Nov;144(5):1058–1064. doi: 10.1164/ajrccm/144.5.1058. [DOI] [PubMed] [Google Scholar]
  34. Kusaka Y., Nakano Y., Shirakawa T., Morimoto K. Lymphocyte transformation with cobalt in hard metal asthma. Ind Health. 1989;27(4):155–163. doi: 10.2486/indhealth.27.155. [DOI] [PubMed] [Google Scholar]
  35. Lemière C., Cartier A., Dolovich J., Chan-Yeung M., Grammer L., Ghezzo H., L'Archevêque J., Malo J. L. Outcome of specific bronchial responsiveness to occupational agents after removal from exposure. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):329–333. doi: 10.1164/ajrccm.154.2.8756802. [DOI] [PubMed] [Google Scholar]
  36. Maestrelli P., Del Prete G. F., De Carli M., D'Elios M. M., Saetta M., Di Stefano A., Mapp C. E., Romagnani S., Fabbri L. M. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health. 1994 Oct;20(5):376–381. doi: 10.5271/sjweh.1383. [DOI] [PubMed] [Google Scholar]
  37. Malo J. L., Boulet L. P., Dewitte J. D., Cartier A., L'Archevêque J., Côté J., Bédard G., Boucher S., Champagne F., Tessier G. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol. 1993 Jun;91(6):1121–1127. doi: 10.1016/0091-6749(93)90313-5. [DOI] [PubMed] [Google Scholar]
  38. Malo J. L., Cartier A., Côté J., Milot J., Leblanc C., Paquette L., Ghezzo H., Boulet L. P. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med. 1996 Mar;153(3):953–960. doi: 10.1164/ajrccm.153.3.8630579. [DOI] [PubMed] [Google Scholar]
  39. Malo J. L., Cartier A., Ghezzo H., Lafrance M., McCants M., Lehrer S. B. Patterns of improvement in spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis. 1988 Oct;138(4):807–812. doi: 10.1164/ajrccm/138.4.807. [DOI] [PubMed] [Google Scholar]
  40. Malo J. L., Cartier A., L'Archevêque J., Ghezzo H., Lagier F., Trudeau C., Dolovich J. Prevalence of occupational asthma and immunologic sensitization to psyllium among health personnel in chronic care hospitals. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1359–1366. doi: 10.1164/ajrccm/142.6_Pt_1.1359. [DOI] [PubMed] [Google Scholar]
  41. Malo J. L., Ghezzo H., L'Archevêque J., Lagier F., Perrin B., Cartier A. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis. 1991 Mar;143(3):528–532. doi: 10.1164/ajrccm/143.3.528. [DOI] [PubMed] [Google Scholar]
  42. Malo J. L., Lemière C., Desjardins A., Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J. 1997 Jul;10(7):1513–1515. doi: 10.1183/09031936.97.10071513. [DOI] [PubMed] [Google Scholar]
  43. Marabini A., Dimich-Ward H., Kwan S. Y., Kennedy S. M., Waxler-Morrison N., Chan-Yeung M. Clinical and socioeconomic features of subjects with red cedar asthma. A follow-up study. Chest. 1993 Sep;104(3):821–824. doi: 10.1378/chest.104.3.821. [DOI] [PubMed] [Google Scholar]
  44. Meredith S. K., Taylor V. M., McDonald J. C. Occupational respiratory disease in the United Kingdom 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med. 1991 May;48(5):292–298. doi: 10.1136/oem.48.5.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Mitchell C. A., Gandevia B. Respiratory symptoms and skin reactivity in workers exposed to proteolytic enzymes in the detergent industry. Am Rev Respir Dis. 1971 Jul;104(1):1–12. doi: 10.1164/arrd.1971.104.1.1. [DOI] [PubMed] [Google Scholar]
  46. Nordman H. Occupational asthma--time for prevention. Scand J Work Environ Health. 1994;20(Spec No):108–115. [PubMed] [Google Scholar]
  47. Paggiaro P. L., Vagaggini B., Bacci E., Bancalari L., Carrara M., Di Franco A., Giannini D., Dente F. L., Giuntini C. Prognosis of occupational asthma. Eur Respir J. 1994 Apr;7(4):761–767. doi: 10.1183/09031936.94.07040761. [DOI] [PubMed] [Google Scholar]
  48. Platts-Mills T. A., Longbottom J., Edwards J., Cockroft A., Wilkins S. Occupational asthma and rhinitis related to laboratory rats: serum IgG and IgE antibodies to the rat urinary allergen. J Allergy Clin Immunol. 1987 Mar;79(3):505–515. doi: 10.1016/0091-6749(87)90369-1. [DOI] [PubMed] [Google Scholar]
  49. Quirce S., Contreras G., Dybuncio A., Chan-Yeung M. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am J Respir Crit Care Med. 1995 Sep;152(3):1100–1102. doi: 10.1164/ajrccm.152.3.7663790. [DOI] [PubMed] [Google Scholar]
  50. Raulf-Heimsoth M., Chen Z., Rihs H. P., Kalbacher H., Liebers V., Baur X. Analysis of T-cell reactive regions and HLA-DR4 binding motifs on the latex allergen Hev b 1 (rubber elongation factor). Clin Exp Allergy. 1998 Mar;28(3):339–348. doi: 10.1046/j.1365-2222.1998.00230.x. [DOI] [PubMed] [Google Scholar]
  51. Saetta M., Maestrelli P., Turato G., Mapp C. E., Milani G., Pivirotto F., Fabbri L. M., Di Stefano A. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):489–494. doi: 10.1164/ajrccm.151.2.7842211. [DOI] [PubMed] [Google Scholar]
  52. Sallie B., McDonald C. Inhalation accidents reported to the SWORD surveillance project 1990-1993. Ann Occup Hyg. 1996 Apr;40(2):211–221. doi: 10.1016/0003-4878(95)00067-4. [DOI] [PubMed] [Google Scholar]
  53. Siracusa A., Kennedy S. M., DyBuncio A., Lin F. J., Marabini A., Chan-Yeung M. Prevalence and predictors of asthma in working groups in British Columbia. Am J Ind Med. 1995 Sep;28(3):411–423. doi: 10.1002/ajim.4700280310. [DOI] [PubMed] [Google Scholar]
  54. Soriano J. B., Ercilla G., Sunyer J., Real F. X., Lázaro C., Rodrigo M. J., Estivill X., Roca J., Rodríguez-Roisín R., Morell F. HLA class II genes in soybean epidemic asthma patients. Am J Respir Crit Care Med. 1997 Nov;156(5):1394–1398. doi: 10.1164/ajrccm.156.5.9701064. [DOI] [PubMed] [Google Scholar]
  55. Tarlo S. M., Boulet L. P., Cartier A., Cockcroft D., Côtè J., Hargreave F. E., Holness L., Liss G., Malo J. L., Chan-Yeung M. Canadian Thoracic Society guidelines for occupational asthma. Can Respir J. 1998 Jul-Aug;5(4):289–300. doi: 10.1155/1998/587580. [DOI] [PubMed] [Google Scholar]
  56. Vandenplas O., Malo J. L. Inhalation challenges with agents causing occupational asthma. Eur Respir J. 1997 Nov;10(11):2612–2629. doi: 10.1183/09031936.97.10112612. [DOI] [PubMed] [Google Scholar]
  57. Venables K. M., Chan-Yeung M. Occupational asthma. Lancet. 1997 May 17;349(9063):1465–1469. doi: 10.1016/S0140-6736(96)07219-4. [DOI] [PubMed] [Google Scholar]
  58. Venables K. M. Prevention of occupational asthma. Eur Respir J. 1994 Apr;7(4):768–778. doi: 10.1183/09031936.94.07040768. [DOI] [PubMed] [Google Scholar]
  59. Walker C., Bode E., Boer L., Hansel T. T., Blaser K., Virchow J. C., Jr Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992 Jul;146(1):109–115. doi: 10.1164/ajrccm/146.1.109. [DOI] [PubMed] [Google Scholar]
  60. Yelin E., Henke J., Katz P. P., Eisner M. D., Blanc P. D. Work dynamics of adults with asthma. Am J Ind Med. 1999 May;35(5):472–480. doi: 10.1002/(sici)1097-0274(199905)35:5<472::aid-ajim4>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  61. Young R. P., Barker R. D., Pile K. D., Cookson W. O., Taylor A. J. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med. 1995 Jan;151(1):219–221. doi: 10.1164/ajrccm.151.1.7812558. [DOI] [PubMed] [Google Scholar]
  62. Zetterström O., Osterman K., Machado L., Johansson S. G. Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J (Clin Res Ed) 1981 Nov 7;283(6301):1215–1217. doi: 10.1136/bmj.283.6301.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES